Acute myelomonocytic leukemia during pembrolizumab treatment for non-small cell lung cancer: A case report

Table 1 Change of complete blood count results after pembrolizumab

CBC (reference values)	Pem-1	Pem-2	Pem-3	HD-0 (3 wk after Pem-3)	HD-7	HD-17	HD-20
WBC (/µL) (4000-8000/µL)	2290	6030	7410	24630	40720	163740	273920
Monocyte (%) (2%-8%)	7.4	5.0	13.6	12.1	18.3	14.9	16.6
Hgb (g/dL) (12-16 g/dL)	7.7	8.8	8.3	8.0	7.4	7.5	5.7
Plt (× 103/µL) (150-400 × 103/µL)	63	228	87	33	52	62	84

CBC: Complete cell count; HD: Hospital day; Hgb: Hemoglobin; Pem-1: 1^st cycle of pembrolizumab; Pem-2: 2^nd cycle of pembrolizumab; Pem-3: 3^rd cycle of pembrolizumab; Plt: Platelet; WBC: White blood cell.